Ocugen OCGN is building its ocular portfolio around a modifier gene therapy idea: instead of designing a therapy for a single genetic defect, the platform is intended to work across many underlying ...

A research team co-led by scientists at the Netherlands Cancer Institute (NKI) and Oncode Institute has developed a deep learning model, PARM (promoter activity regulatory model) that offers up new ...

Disruptions in transcriptional regulation during hematopoiesis can lead to abnormal hematopoietic differentiation and the development of leukemia. Understanding the underlying mechanisms of disease ...

Researchers at the Weill Institute for Cell and Molecular Biology have uncovered new evidence that two major types of gene-controlling DNA sequences, promoters and enhancers, operate with a shared ...

The PhD student with a background in physics, is not only focused on the performance of statistical models for genomic predictions but is also keen on understanding the underlying biological ...

By Tarun Sai Lomte Scientists reveal how evolution within our own tissues can drive disease, protect cells, and uncover hidden therapeutic targets for future precision medicine. Somatic genomics ...

Invivoscribe, a global leader in precision diagnostics, is pleased to announce the successful listings of the LeukoStrat CDx FLT3 Mutation Assay in both the United Kingdom (UK) and Switzerland. The ...

The results of newly reported preclinical research indicate that a genetic mutation that helps animals including yaks and Tibetan antelopes survive at high altitudes may hold the key to repairing ...